Inventor

MANTEI ROBERT A

US24 patents

⚠️ This page may combine multiple inventors who share the name “MANTEI ROBERT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MANTEI ROBERT A

ABBVIE INC

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

Dihydro-pyrrolopyridinone inhibitors

Bromodomain inhibitors

Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors

ABBOTT LAB

Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors

Sulfonamides having antiangiogenic and anticancer activity

Non-peptide renin inhibitors

Farnesyltransferase inhibitors

Farnesyltransferase inhibitors

Urea kinase inhibitors

Pyrimidine inhibitors of kinase activity

BRUNCKO MILAN

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

BA-MAUNG NWE Y

Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition

Protein kinase inhibitors

DOHERTY GEORGE A

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

WANG GARY T

Pyrimidine inhibitors of kinase activity

CLARK RICHARD F

Pyrimidine inhibitors of kinase activity